Dear Toobiters,
We are thrilled to announce that Toobit is listing Aspecta (ASP) on Toobit Spot.
The listing schedule is as follows:
- Deposits: Opened
- Trading: Opened
- Withdrawals: 2025-07-29
- Spot trading link: ASP/USDT
- Trading Zone: RWA
About Aspecta
Aspecta addresses a fundamental gap in capital markets: early-stage or locked assets often enter public markets without transparent pricing, creating volatility and mistrust. Its solution includes BuildKey, a framework that standardizes illiquid assets into ERC-20-like credentials allowing open on-chain price discovery, and Build Attestation (Aspecta ID), an AI-powered reputation protocol that helps developers and early projects build trust and signal credibility. Together, these tools enable illiquid assets to be represented, attested, and traded more openly – laying the groundwork for an open, inclusive market for “alpha assets.”
Transaction Network (SOL): https://solscan.io/token/DJ7vji2BU7RjNgktPAKN4L42CiXTFHEt4Eeeyr5FiTmy
Small balance conversion
- Small balance conversion will list ASP on 2025-07-28 (UTC).
We are excited to welcome the Aspecta community to Toobit and look forward to a successful launch. Thank you for your continued support.
Toobit Team
2025-07-28
Find us:
X: https://x.com/Toobit_official
Telegram: https://t.me/Toobit_EN
Discord: https://discord.com/invite/vvxTuGTz
YouTube: https://www.youtube.com/@Toobit_official
Reddit: https://www.reddit.com/r/toobit/
Facebook: https://www.facebook.com/toobitofficial
Medium: https://medium.com/toobit-exchange
Toobit reserves the right to modify or cancel this announcement at any time and for any reason without prior notice.
Risk Warning: The prices of digital assets may fluctuate significantly. The value of your investment may increase or decrease, and you may even lose the entire amount invested. You are solely responsible for your investment decisions, and Toobit is not liable for any losses that may occur due to the use of margin trading. This information should not be considered financial or investment advice. Please refer to our Terms of Use and Risk Disclosure for more details.